Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...
The patient was diagnosed as Acute Myeloid Leukemia (AML) M 1 (according to French–American–British classification ... Thorough search of literature revealed that the first case of circulating MMGK ...
A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...
News Medical on MSN4d
Innovative triplet therapy shows encouraging results in advanced chronic myeloid leukemiaAccording to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Positive preliminary outcomes were reported for the first leukemia patient treated with Ossium Health's organ donor bone ...
19, 2024 /PRNewswire/ -- Lucinity and Sift have announced a partnership, unifying fraud and Anti-Money Laundering (AML) into Lucinity's integrated FinCrime compliance platform for case management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback